Reports for EFAVIRENZ

Ingredient

EFAVIRENZ

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2020-04-16 2020-05-08 112370
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2022-06-03 2023-02-11 161940
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-04-14 2023-07-07 189653
JAMP-EFAVIRENZ 600MG TABLET Resolved 2022-04-06 2022-07-20 158082
PMS-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 300MG 200MG TABLET Resolved 2022-08-15 2022-10-24 166805
TEVA-EFAVIRENZ 600MG TABLET Resolved 2020-05-01 2020-06-11 113782

Showing 1 to 10 of 17

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260
SUSTIVA 200MG 200MG CAPSULE Discontinued 2021-06-14 2023-04-01 140881
SUSTIVA 50MG 50MG CAPSULE Discontinued 2021-06-14 2023-04-01 140884
SUSTIVA TABLETS 600MG TABLET Discontinued 2021-06-14 2022-10-01 140887

Showing 1 to 4 of 4